Corient Private Wealth LLC Purchases 5,995 Shares of MKS Inc. $MKSI

Corient Private Wealth LLC increased its position in shares of MKS Inc. (NASDAQ:MKSIFree Report) by 102.3% during the 4th quarter, Holdings Channel reports. The firm owned 11,855 shares of the scientific and technical instruments company’s stock after purchasing an additional 5,995 shares during the quarter. Corient Private Wealth LLC’s holdings in MKS were worth $1,898,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. USA Financial Formulas bought a new position in shares of MKS in the fourth quarter valued at approximately $26,000. Global Retirement Partners LLC lifted its holdings in MKS by 560.0% during the fourth quarter. Global Retirement Partners LLC now owns 165 shares of the scientific and technical instruments company’s stock worth $26,000 after acquiring an additional 140 shares during the period. IFP Advisors Inc lifted its holdings in MKS by 616.7% during the fourth quarter. IFP Advisors Inc now owns 172 shares of the scientific and technical instruments company’s stock worth $27,000 after acquiring an additional 148 shares during the period. Danske Bank A S purchased a new position in MKS in the third quarter worth $37,000. Finally, CIBC Private Wealth Group LLC grew its stake in MKS by 55.2% in the 4th quarter. CIBC Private Wealth Group LLC now owns 256 shares of the scientific and technical instruments company’s stock valued at $41,000 after purchasing an additional 91 shares during the period. 99.79% of the stock is owned by institutional investors.

Insider Activity at MKS

In related news, EVP David Philip Henry sold 2,500 shares of the firm’s stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $330.50, for a total value of $826,250.00. Following the completion of the transaction, the executive vice president directly owned 16,341 shares of the company’s stock, valued at approximately $5,400,700.50. This trade represents a 13.27% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gerald G. Colella sold 20,000 shares of MKS stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $333.40, for a total transaction of $6,668,000.00. Following the completion of the transaction, the director owned 20,017 shares of the company’s stock, valued at $6,673,667.80. This represents a 49.98% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 53,949 shares of company stock worth $17,446,108 in the last ninety days. Insiders own 0.57% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on MKSI shares. Wells Fargo & Company raised their target price on MKS from $255.00 to $300.00 and gave the company an “equal weight” rating in a research report on Friday, May 8th. KeyCorp increased their price target on shares of MKS from $360.00 to $475.00 and gave the company an “overweight” rating in a research report on Monday. JPMorgan Chase & Co. raised their price objective on shares of MKS from $305.00 to $365.00 and gave the stock an “overweight” rating in a report on Friday, May 8th. Citigroup lifted their price objective on shares of MKS from $290.00 to $355.00 and gave the stock a “buy” rating in a research report on Friday, May 8th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of MKS in a research note on Tuesday, April 21st. Two investment analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $368.00.

Get Our Latest Report on MKSI

MKS Stock Up 7.0%

MKSI stock opened at $416.00 on Tuesday. The stock has a fifty day moving average of $325.85 and a 200-day moving average of $255.89. MKS Inc. has a fifty-two week low of $88.49 and a fifty-two week high of $421.58. The company has a market capitalization of $28.10 billion, a price-to-earnings ratio of 87.03, a PEG ratio of 1.11 and a beta of 1.99. The company has a debt-to-equity ratio of 0.94, a quick ratio of 0.70 and a current ratio of 1.11.

MKS (NASDAQ:MKSIGet Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The scientific and technical instruments company reported $2.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.00 by $0.30. The business had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. MKS had a return on equity of 21.49% and a net margin of 8.06%.The firm’s quarterly revenue was up 15.2% compared to the same quarter last year. During the same period in the previous year, the business posted $1.71 EPS. MKS has set its Q2 2026 guidance at 2.600-3.200 EPS. As a group, equities research analysts predict that MKS Inc. will post 11.73 earnings per share for the current year.

MKS Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, June 12th. Investors of record on Wednesday, June 3rd were paid a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date was Wednesday, June 3rd. MKS’s dividend payout ratio is presently 20.92%.

MKS Company Profile

(Free Report)

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.

Further Reading

Want to see what other hedge funds are holding MKSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MKS Inc. (NASDAQ:MKSIFree Report).

Institutional Ownership by Quarter for MKS (NASDAQ:MKSI)

Receive News & Ratings for MKS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MKS and related companies with MarketBeat.com's FREE daily email newsletter.